L.J. Altfest & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,376
Closed -$1.66M 337
2025
Q4
$1.66M Buy
17,376
+4,814
+38% +$472K 0.18% 93
2025
Q3
$1.23M Sell
12,562
-5,840
-32% -$605K 0.14% 114
2025
Q2
$1.98M Buy
18,402
+3,872
+27% +$392K 0.23% 79
2025
Q1
$1.47M Buy
14,530
+402
+3% +$40.5K 0.18% 91
2024
Q4
$1.26M Buy
14,128
+2,077
+17% +$183K 0.16% 98
2024
Q3
$1.01M Sell
12,051
-372
-3% -$29.3K 0.13% 131
2024
Q2
$957K Buy
12,423
+2,703
+28% +$198K 0.13% 119
2024
Q1
$666K Buy
9,720
+3,243
+50% +$209K 0.09% 158
2023
Q4
$374K Sell
6,477
-6,821
-51% -$364K 0.05% 224
2023
Q3
$702K Buy
13,298
+208
+2% +$10.9K 0.11% 137
2023
Q2
$708K Sell
13,090
-200
-2% -$10.4K 0.11% 135
2023
Q1
$665K Buy
13,290
+17
+0.1% +$801 0.1% 133
2022
Q4
$614K Buy
13,273
+2,683
+25% +$116K 0.1% 139
2022
Q3
$410K Buy
10,590
+37
+0.4% +$1.48K 0.08% 166
2022
Q2
$393K Buy
+10,553
New +$430K 0.07% 172
2021
Q1
Sell
-25,164
Closed -$905K 279
2020
Q4
$905K Buy
25,164
+2,680
+12% +$96.6K 0.22% 85
2020
Q3
$859K Buy
22,484
+3,366
+18% +$130K 0.23% 79
2020
Q2
$671K Buy
19,118
+12,774
+201% +$460K 0.19% 86
2020
Q1
$207K Buy
+6,344
New +$248K 0.06% 183

Other funds holding BSX

L.J. Altfest & Co's BSX Position: Q1 2026 in Review

L.J. Altfest & Co sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 17,376 shares — an estimated $1.66M sold.

L.J. Altfest & Co first reported a position in BSX in Q1 2020 and held it in 19 quarters. The position peaked at $1.98M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • L.J. Altfest & Co reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • L.J. Altfest & Co sold 17,376 Boston Scientific shares in Q1 2026, an estimated $1.66M.
  • L.J. Altfest & Co first reported a position in Boston Scientific in Q1 2020 and held it in 19 quarters.
  • L.J. Altfest & Co's Boston Scientific position peaked at $1.98M in Q2 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on L.J. Altfest & Co's 13F filing for Q1 2026, filed 28 Apr 2026.